UCSF MS Epic Study Group.
Plain Language Health, San Francisco, CA, USA.
Mult Scler. 2021 Aug;27(9):1432-1441. doi: 10.1177/1352458520968814. Epub 2020 Nov 25.
In persons with multiple sclerosis (MS), the Expanded Disability Status Scale (EDSS) is the criterion standard for assessing disability, but its in-person nature constrains patient participation in research and clinical assessments.
The aim of this study was to develop and validate a scalable, electronic, unsupervised patient-reported EDSS (ePR-EDSS) that would capture MS-related disability across the spectrum of severity.
We enrolled 136 adult MS patients, split into a preliminary testing Cohort 1 ( = 50), and a validation Cohort 2 ( = 86), which was evenly distributed across EDSS groups. Each patient completed an ePR-EDSS either immediately before or after a MS clinician's Neurostatus EDSS evaluation.
In Cohort 2, mean age was 50.6 years (range = 26-80) and median EDSS was 3.5 (interquartile range (IQR) = [1.5, 5.5]). The ePR-EDSS and EDSS agreed within 1-point for 86% of examinations; kappa for agreement within 1-point was 0.85 ( < 0.001). The correlation coefficient between the two measures was 0.91 (<0.001).
The ePR-EDSS was highly correlated with EDSS, with good agreement even at lower EDSS levels. For clinical care, the ePR-EDSS could enable the longitudinal monitoring of a patient's disability. For research, it provides a valid and rapid measure across the entire spectrum of disability and permits broader participation with fewer in-person assessments.
在多发性硬化症(MS)患者中,扩展残疾状况量表(EDSS)是评估残疾的标准,但它的现场性质限制了患者参与研究和临床评估。
本研究旨在开发和验证一种可扩展的、电子的、无需监督的患者报告的 EDSS(ePR-EDSS),以捕捉整个严重程度范围内的 MS 相关残疾。
我们招募了 136 名成年 MS 患者,分为初步测试队列 1(n=50)和验证队列 2(n=86),队列 2 患者的 EDSS 评分均匀分布在各个组。每位患者在接受 MS 临床医生的神经状态 EDSS 评估之前或之后完成一份 ePR-EDSS。
在队列 2 中,平均年龄为 50.6 岁(范围=26-80),中位数 EDSS 为 3.5(四分位距(IQR)=[1.5, 5.5])。ePR-EDSS 和 EDSS 在 86%的检查中相差 1 分;1 分以内的一致性的kappa 值为 0.85(<0.001)。两种测量方法之间的相关系数为 0.91(<0.001)。
ePR-EDSS 与 EDSS 高度相关,即使在较低的 EDSS 水平也具有良好的一致性。对于临床护理,ePR-EDSS 可以实现患者残疾的纵向监测。对于研究,它提供了一种有效的、快速的衡量整个残疾范围的方法,并允许更广泛的参与,减少现场评估。